John W Hollis Inc Recalls Liver Derivative Complex Injection for Sterility Concerns
John W Hollis Inc is recalling specific lots of Liver Derivative Complex for injection due to a lack of assurance of sterility in the compounded aseptically filled products.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of sterility assurance in injectable products, which poses a significant risk of serious injury or death from infection, meeting the criteria for a Severe rating.
Plain-English summary
John W Hollis Inc is recalling specific lots of Liver Derivative Complex for injection. The product is a compounded prescription medication containing Liver Derivative Complex, Water for Injection, Phenol, and pH adjusters. The recall involves 1,560 mL of the product distributed nationwide.
The recall was initiated due to a lack of assurance of sterility in the compounded aseptically filled injectable products. The affected lots include Lot #938 (Use by 08/17/14), Lot #1370 (Use by 11/08/14 or 1/30/15), and Lot #2664 (Use by 4/18/15).
Consumers and healthcare providers should check their inventory for these specific lot numbers and discontinue use if found. The FDA has classified this as a Class II recall.
The recalled product
- Product
- Liver Derivative Complex for injection, each mL contains: Liver Derivative Complex 25.5mg, also contains: Water for Injection, Phenol 0.5%, HCl or NaOH to adjust pH, 10 mL, Compounded by Prescription: JOHN HOLLIS Pharmacist Inc, 110 20th Avenue N, Nashville, TN 37203, 615-327-32
- Manufacturer
- John W Hollis Inc
- Category
- Drug — Injectable Compounded
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot# 938
- Use by 08/17/14
- Lot #1370
- Use by Lot# 1818
- Use by 11/08/14
- 1/30/15
- Lot# 2664
- Use by 4/18/15
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 19 recalled by John W Hollis Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 19 products in this recall →Related recalls
Same manufacturer · John W Hollis Inc
See all →- SevereJohn W Hollis Inc Recalls Compounded Injectable Products Due to Sterility Concerns
FDA (Drugs) · 2014-06-25
- SevereJohn W Hollis Inc Recalls Compounded Injectable Drug Due to Sterility Concerns
FDA (Drugs) · 2014-06-25
- SevereJohn W Hollis Inc Recalls Methylcobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2014-06-25
- SevereJohn W Hollis Recalls Polidocanol Injection Due to Sterility Concerns
FDA (Drugs) · 2014-06-25
- SevereJohn W Hollis Recalls Polidocanol 1% Injection Due to Sterility Concerns
FDA (Drugs) · 2014-06-25
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29